Give more people weight loss jabs on the NHS, say MPs

MPs have criticised the NHS rollout of the weight-loss drug Mounjaro, describing the current strategy as unambitious. Reports indicate that only approximately 6% of eligible patients are expected to receive the medication within its first three years of availability on the NHS. Consequently, lawmakers are calling for an increase in the number of people granted access to these weight-loss jabs by 2028 to ensure more eligible patients can benefit from the treatment across the healthcare system.